How do you pay?

How to pay the least

Ask for the cash price

Aranesp

Aranesp is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for Aranesp’s cash price, and one or two other pharmacies too.

Other ways

Free from the maker, if you qualify Amgen Safety Net Foundation. Amgen Safety Net Foundation income requirements are based on a percentage of the Federal Poverty Level, adjusted for household size. Or call 1-800-932-3060.

See if you qualify 

Compare every option

Brand name

Aranesp, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from Aranesp’s maker. Ask the pharmacy for Aranesp’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Aranesp is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldNone sold yet

What it’s used for

What the FDA label says

Aranesp is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to:

  • Chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis.
  • The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.

Limitations of Use Aranesp has not been shown to improve quality of life, fatigue, or patient well-being.

Aranesp is not indicated for use:

  • In patients with cancer receiving hormonal agents, biologic products, or radiotherapy, unless also receiving concomitant myelosuppressive chemotherapy.
  • In patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure.
  • In patients with cancer receiving myelosuppressive chemotherapy in whom the anemia can be managed by transfusion.
  • As a substitute for RBC transfusions in patients who require immediate correction of anemia.

Source: the FDA label for Aranesp (Amgen, Inc), July 7, 2026. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Aranesp’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.